<DOC>
	<DOCNO>NCT00416221</DOCNO>
	<brief_summary>Researchers University California San Diego ( UCSD ) conduct 12-week study test PACEPRO program . This program design reduce depression providing : Lexapro , antidepressant medicine…Learn More Physical activity information pedometer Mood management skill Mood Mastery Guide Personalized support Family Nurse Practitioner</brief_summary>
	<brief_title>PACEPro - Mood Management Pilot</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Have diagnose mild moderate depression Are willing take antidepressant Lexapro Can access use Email Internet Are willing able physically active Access primary care physician Subjects exclude participation follow reason : Pregnancy breastfeed Narrow angle glaucoma Any uncontrolled medical condition medical condition would represent contraindication Escitalopram Oxalate Lexapro® pharmacotherapy . Any concomitant nonpsychotropic medication physician determines contraindication Escitalopram Oxalate Lexapro® pharmacotherapy Bipolar disorder , psychotic organic mental disorder dementia History intolerance allergy Lexapro , prior fail treatment depression Lexapro Current substance abuse dependency Current active suicidal ideation Current use herbal psychoactive treatment St. John 's Wort Concurrent psychotropic medication permit 2 week prior randomization ( 4 week case fluoxetine ) point Receipt formal psychotherapy concurrently Inability , investigator 's opinion , comply study procedures assessment Inability exercise</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Depression</keyword>
	<keyword>Lexapro</keyword>
</DOC>